Nxera Pharma Co., Ltd.

SOLTF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$192$32,997$34,465$36,203
Short-Term Investments$0$33$0$0
Receivables$66$6,803$4,462$6,695
Inventory$65$8,718$8,767$8,838
Other Curr. Assets$23$5,241$5,505$6,119
Total Curr. Assets$347$53,792$53,199$57,855
Property Plant & Equip (Net)$45$6,879$7,097$7,468
Goodwill$175$25,799$25,514$25,693
Intangibles$338$50,586$51,085$51,911
Long-Term Investments$30$3,656$3,947$4,550
Tax Assets$40$3,977$0$0
Other NC Assets$0$0$4,847$4,021
Total NC Assets$628$90,897$92,490$93,643
Other Assets$0$0$0$0
Total Assets$975$144,689$145,689$151,498
Liabilities
Payables$34$4,435$4,055$4,052
Short-Term Debt$45$6,676$6,682$6,690
Tax Payable$0$213$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$32$3,546$3,559$4,890
Total Curr. Liab.$110$14,870$14,296$15,632
LT Debt$382$58,047$59,582$61,210
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$6$986$0$1,857
Other NC Liab.$33$4,925$4,740$4,281
Total NC Liab.$420$63,958$64,322$67,348
Other Liabilities$0$0$0$0
Cap. Leases$19$3,942$4,111$4,375
Total Liabilities$531$78,828$78,618$82,980
Equity
Pref Stock$0$0$0$0
Common Stock$321$47,450$47,172$47,172
Retained Earnings-$75-$9,458-$21,702-$20,942
AOCI$52$6,852$6,143$7,217
Other Equity$146$21,017$35,458$35,071
Total Equity$444$65,861$67,071$68,518
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$975$144,689$145,689$151,498
Net Debt$234$31,726$31,799$31,697